Join us for a discussion on Medical Cannabis with Dr Chris Spooner ND and Dr Philippe Henry, PhD Biology Tim Dyer, Registered Pharmacist
Philippe Henry, PhD, is the founder and Chief Science Officer with VSSL Enterprises LTd. He is a population geneticist who uses genomic data to advance the understanding of the genetic basis of key traits of the cannabis plant and its therapeutic potential. Dr. Henry’s recent work has focused on the development of statistical approaches to modeling the chemotypic variation in elite cannabis cultivars and correlating that information with genomic data with the goal of using sound science to objectively guide cannabis breeding efforts and product development. Along with numerous published papers in scientific journals, Dr. Henry is the co-author of a recent preprint article, “Predicting chemovar cluster and variety verification in vegetative cannabis accessions using targeted single nucleotide polymorphisms” (https://peerj.com/preprints/27442/).
His talk will focus on the interface between cannabis chemotypes and the underlying basis of people’s responses to cannabis as a therapeutic agent and recreational substance